lusutrombopag,
Mulpleta,
LUSUTROMBOPAG,
1110766-97-6,
mulpleta,
UNII-6LL5JFU42F,
6LL5JFU42F,
S-888711,
(S,E)-3-(2,6-Dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid,
2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-,
Lusutrombopag [USAN:INN],
2-Propenoic acid, 3-(2,6-dichloro-4-(((4-(3-((1S)-1-(hexyloxy)ethyl)-2-methoxyphenyl)-2-thiazolyl)amino)carbonyl)phenyl)-2-methyl-, (2E)-,
S 888711,
SCHEMBL3062080,
SCHEMBL3062084,
CHEMBL2107831,
Lusutrombopag (JAN/USAN/INN),
GTPL10032,
CHEBI:136051,
BCP18563,
EX-A1290,
MFCD28502075,
ZINC84759273,
CS-6137,
DB13125,
SB16975,
(2E)-3-(2,6-Dichloro-4-((4-(3-((1S)-1-(hexyloxy)ethyl)- 2-methoxyphenyl)-1,3-thiazol-2-yl)carbamoyl)phenyl)-2-methylprop-2-enoic acid,
AS-52368,
HY-19883,
Lusutrombopag pound S-888711 pound(c),
J3.505.027B,
D10476,
S888711,
(2E)-3-(2,6-Dichloro-4-((4-(3-((1S)-1-(hexyloxy)ethyl)-2-methoxyphenyl)-1,3-thiazol-2-yl)carbamoyl)phenyl)-2-methylprop-2-enoic acid,
(E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid,
Lusutrombopag [INN],
C000611387,